Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term lung cancer. Found 27 abstracts

no pagination
Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LM, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer cell. 2018 Apr 12;33(5):843-852 e4.   PMCID: PMC5953836
Jung K, Park JC, Kang H, Brandes J. Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the US veterans with prostate cancer. Epidemiology and health. 2018 Aug 11;.
Mortazavi SM, Bevelacqua JJ, Fornalski KW, Pennigton CW, Welsh J, Janiak MK, Dobrzynski L, Doss M. Letter to the Editor (August 24, 2017) concerning the paper "Occupational exposure to radon for underground tourist routes in Poland: Doses to lung and the risk of developing lung cancer". International journal of occupational medicine and environmental health. 2018 Oct 24;31(5):703-6.
Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Medical sciences (Basel, Switzerland). 2018 Oct 24;6(4).   PMCID: PMC6313571
Bassi DE, Zhang J, Renner C, Klein-Szanto AJ. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Mol Carcinog. 2017 Mar;56(3):1182-8.   PMCID: PMC6166887
Tokar JJ, Warrick JW, Guckenberger DJ, Sperger JM, Lang JM, Ferguson JS, Beebe DJ. Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte Extraction. SLAS technology. 2017 Jun;22(3):348-57.   PMCID: PMC5603149
Kudinov AE, Deneka A, Nikonova AS, Beck TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, Cai KQ, Yaghmour KM, Baker KA, Egleston BL, Nicolas E, Chikwem A, Andrianov G, Singh S, Borghaei H, Serebriiskii IG, Gibbons DL, Kurie JM, Golemis EA, Boumber Y. Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6955-60.   PMCID: PMC4922167
Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman MA, Meyer JE. Absence of pathological proof of cancer associated with improved outcomes in early stage lung cancer. J Thorac Oncol. 2016 Jul;11(7):1112-20.
Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D, Nicholson A, Powell CA, Prokop M, Rami-Porta R, Rusch V, van Schil P, Yatabe Y. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016 Aug;11(8):1204-23.
Kang SW, Lang JY, Wang P, Li J, Lin MH, Chen XM, Guo M, Chen F, Chen LL, Ma CM. Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers. Journal of Applied Clinical Medical Physics. 2014 Jan;15(3):102-13.
Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yip R, Yankelevitz DF, Henschke CI. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer. 2007 May;56(2):193-9.
Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. JOURNAL OF THORACIC ONCOLOGY. 2006 Jul;1(6):526-31.
Crawford J, Kosmidis PA, Hirsch FR, Langer CJ. Targeting anemia in patients with lung cancer. JOURNAL OF THORACIC ONCOLOGY. 2006 Sep;1(7):716-25.
Flieder DB, Vazque M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yankelevitz DF, Heimschke CI. Pathologic findings of lung tumors diagnosed on baseline CT screening. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2006 May;30(5):606-13.
Thunnissen FB, Kerr KM, Brambilla E, Comin CE, Franklin WA, Guldhammerskov B, Westra WH, Flieder DB. EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. European Respiratory Journal. 2006 Dec;28(6):1186-9.
Travis WD, Garg K, Franklin WA, Wistuba, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. Journal of Thoracic Oncology. 2006 Nov;1(9):S13-S19.
Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current US practice with chemotherapy in the non-metastatic setting follow the literature?. Lung Cancer. 2005 Apr;48(1):93-102.
Treat J. Incorporating novel agents with gemicitabine-based treatment of NSCLC. Lung Cancer. 2005 Oct;50:S8-S9.
Xu M, Floyd HS, Greth SM, Chang WC, Lohman K, Stoyanova R, Kucera GL, Kute TE, Willingham MC, Miller MS. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Toxicology and Applied Pharmacology. 2004 Mar;195(2):232-46.
Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04. International Journal of Radiation Oncology Biology Physics. 2002 Jul;53(3):548-57.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term lung cancer

lung cancer cancer pathology screening bronchioloalveolar carcinoma adenocarcinoma cisplatin chemotherapy oncology prostate cancer concurrent radiation therapy double-blind LUNG-CANCER minimally invasive adenocarcinoma atypical adenomatous hyperplasia trial nonplatinum chemotherapy patients receiving chemotherapy CT scan darbepoetin-alpha Msi2 RATE RADIOTHERAPY Poland bronchoalveolar hemoglobin THIN-SECTION CT resected stage-ii EPITHELIAL-CELLS IMRT biopsy adjuvant chemotherapy Nuclear Medicine & Medical Imaging Radiology radiology gemcitabine clinical automation hormonal therapy placebo-controlled trial combination microarray novel agents risk prognosis KeyWords Plus: tumor size erythropoietin project apoptosis CARCINOGENESIS lepidic predominant adenocarcinoma occupational exposure ACTION PROJECT therapy-oncology-group randomized-trial initial treatment microtechnology transfusion requirements spiral computed-tomography INDUCTION immunotherapy PERIPHERAL claudins COMPUTED-TOMOGRAPHY phase-iii trial recurrent cancer early stage SMALL ADENOCARCINOMA classification CT carboplatin anemia proprotein convertases epidemiology SURVIVAL tumor development MONOTERPENES CANCER patterns of care survey surgery pulsed low-dose-rate radiotherapy (PLDR) clinical trial Ctla-4 radiation-therapy Nsclc GROUND-GLASS OPACITY Pathology PROGNOSTIC-SIGNIFICANCE stage-ii TNM classification quality-of-life INDUCED REGRESSION Tmb hyperfractionated radiation-therapy furin cell lung-cancer Pd-1 HIGH-RESOLUTION CT metaanalysis breast cancer inpatient psychiatry colorectal cancer PROTEIN ISOPRENYLATION combination chemotherapy H&N therapy androgen deprivation therapy small adenocarcinoma GENE Igf-1r US veterans CARCINOMA epoetin alfa mutation burden Pcskc3 EXPRESSION HYPERSENSITIVITY Sbrt ADENOCARCINOMA community oncology radon CELLS non-small-cell lung cancer thoracic radiotherapy carcinoma chemoradiation underground routes radiotherapy lavage lung cancer staging Mdd diagnosis Surgery COUNTY D-LIMONENE monoterpene Adenocarcinoma in situ metastasis RECEPTOR pattern of care clinical-trials RETREATMENT STRATEGY GEFITINIB MAMMARY-TUMORS solid-phase extraction APOPTOSIS panel lab on a chip epoetin-alpha
Last updated on Wednesday, February 05, 2020